These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10390397)

  • 1. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
    Snyder DC; Paz EA; Mohle-Boetani JC; Fallstad R; Black RL; Chin DP
    Am J Respir Crit Care Med; 1999 Jul; 160(1):178-85. PubMed ID: 10390397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
    Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC
    J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
    Schwartzman K; Menzies D
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
    Daley CL; Hahn JA; Moss AR; Hopewell PC; Schecter GF
    Am J Respir Crit Care Med; 1998 Jan; 157(1):19-22. PubMed ID: 9445273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine.
    Nettleman MD; Geerdes H; Roy MC
    Arch Intern Med; 1997 May; 157(10):1121-7. PubMed ID: 9164378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of methadone maintenance treatment in HIV/AIDS control among injecting drug users in Dehong, China.
    Xing Y; Sun J; Cao W; Lee L; Guo H; Li H; Duan S
    AIDS Care; 2012; 24(6):756-62. PubMed ID: 22149005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
    Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and treatment of tuberculosis in a methadone maintenance treatment program.
    Lee HK; Bluestone H; Frances R
    Hosp Community Psychiatry; 1994 Aug; 45(8):759-60, 764. PubMed ID: 7982689
    [No Abstract]   [Full Text] [Related]  

  • 12. A tuberculin screening and isoniazid preventive therapy program in an inner-city population.
    Bock NN; Metzger BS; Tapia JR; Blumberg HM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):295-300. PubMed ID: 9872853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
    Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
    Tran BX; Ohinmaa A; Duong AT; Do NT; Nguyen LT; Mills S; Houston S; Jacobs P
    AIDS Care; 2012; 24(3):283-90. PubMed ID: 21936718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study.
    Wammes JJ; Siregar AY; Hidayat T; Raya RP; van Crevel R; van der Ven AJ; Baltussen R
    Int J Drug Policy; 2012 Sep; 23(5):358-64. PubMed ID: 22884538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
    Batki SL; Gruber VA; Bradley JM; Bradley M; Delucchi K
    Drug Alcohol Depend; 2002 May; 66(3):283-93. PubMed ID: 12062463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
    Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
    Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.